Jennifer Zachary has served as Executive Vice President and General Counsel at Merck & Co., Inc. since April 2018, where she functions as a principal legal advisor to the company’s board of directors and senior management. In this capacity, she holds significant oversight responsibilities across legal, regulatory, compliance, and corporate governance matters for one of the world’s leading pharmaceutical companies.
Professional Background and Education
Prior to joining Merck, Ms. Zachary built a robust foundation in life sciences regulatory law and corporate counsel roles:
- From 2005 to 2011, she was Associate Chief Counsel for Enforcement at the U.S. Food and Drug Administration (FDA), where she specialized in enforcement matters related to food, drug, and device regulations.
- Between 2011 and 2018, she was a partner and practicing attorney at Covington & Burling LLP, a prominent international law firm, focusing on food, drug, and medical device regulatory practice.
- Her legal education includes a J.D. from Harvard Law School. Additionally, she holds a B.S. in Biology and a B.A. in Chemistry from Arizona State University, underscoring her strong scientific background.
Current Role and Responsibilities at Merck
At Merck, Jennifer Zachary is a key member of the executive leadership team, overseeing all legal functions globally. She advises the board directly and supports Merck's efforts in regulatory compliance, litigation management, intellectual property protection, and corporate governance. Her role extends to guiding the company’s strategy on emerging life sciences regulatory policies and enforcement challenges.
Ms. Zachary also serves on external boards relevant to the life sciences sector, including her position as an Independent Director at REGENXBIO, Inc. since 2022, where she contributes governance insight and legal expertise. She is actively engaged in industry-wide initiatives such as:
- Antimicrobial Resistance (AMR) collaboration efforts, where she advocates for accelerated, global multi-stakeholder actions to combat AMR threats, reflecting her commitment to public health challenges.
- Supporting Merck’s sustainability and climate goals, including the company’s announcement to achieve carbon neutrality in operations by 2025, leveraging legal and policy frameworks to ensure compliance and progressive innovation.
Recognition and Influence
Jennifer Zachary is recognized within both Merck and the wider biotechnology and pharmaceutical sectors as a leading legal executive. She has been acknowledged among influential women executives in the biopharmaceutical industry. She has been publicly profiled in corporate governance documents, including Merck’s:
- Proxy Statements and SEC Filings, where she signs on behalf of Merck as Executive Vice President and General Counsel, signifying her authority in fiscal and compliance disclosures.
- Legal announcements addressing patent litigations and regulatory issues, exemplifying her role in protecting Merck’s intellectual property and business interests.
Location and Contact Context
Merck & Co., Inc. is headquartered in Rahway, New Jersey (126 East Lincoln Avenue, Rahway, NJ 07065), with Jennifer Zachary’s functions centralized in this corporate context. The company operates under the ticker symbol NYSE: MRK.
Jennifer Zachary’s combined scientific education and extensive regulatory and legal experience position her as a critical strategic advisor to Merck’s executive team, especially in navigating complex life sciences regulatory landscapes, compliance enforcement, and corporate governance. Her public leadership role in sustainability and antimicrobial resistance initiatives indicates a broad engagement with global health and environmental challenges relevant to pharmaceutical industry trends and risk management.
